Discover More Life Sciences Events in South Korea

Amongst established global biopharma powerhouses like the US and China, how does South Korea carve out its own innovation leadership position?

Through active government investment into AI and in silico capabilities, combined with a uniquely collaborative culture for novelty, as seen through prominent partnerships from companies like 1st Biotherapeutics, Galux, Pharos iBio and SK Biopharmaceuticals, Korea is emerging as a distinct hub for drug discovery excellence to develop differentiated platforms that will deliver best-in-class, impactful breakthroughs.

The World Novel Drug Discovery Summit South Korea is the first and only industry-led forum empowering K-Bio to accelerate innovation and strengthen its position as a globally recognised and competitive drug discovery powerhouse.

Under the theme of accelerating future best-in-class platforms for next-generation modalities by integrating AI for smarter, faster and de-risked drug discovery, this inaugural forum will bring together 100+ K-Bio innovators, international pharma leaders and industry-renowned service providers to dive into cutting-edge technologies, proven drug discovery strategies, and collaborative networking opportunities to empower best-in-class Korean platforms and position K-Bio for global partnering and licensing opportunities.

If you are working in drug discovery, this is where you need to be to generate new insights and connections to enable safer, faster and seamless drug discovery.